ACADIA Pharmaceuticals Inc (ACAD)
39.88
-0.35 -0.87%
NASDAQ
Aug 12, 16:59
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 393.08M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.47 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -225.18M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 95.03% |
| Profit Margin (Quarterly) | -38.27% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 6.288B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 15.53 |
| PE Ratio | -- |
| Price to Book Value | 9.484 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -39.82M |
| Return on Equity | Upgrade |
View All ACAD News
News
-
WireHeadlineTime (ET)
-
Business Wire08/12 09:00
-
Yahoo08/06 13:19
-
MT Newswires08/06 12:35
-
Yahoo08/05 18:25
-
MT Newswires08/05 17:03
-
MT Newswires08/05 16:26
-
Business Wire08/05 16:05
-
Yahoo07/31 20:00
-
Yahoo07/30 15:37
-
Yahoo07/29 12:33
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 10/30/2020 16:30 EDT | Misc | ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020 |
| 10/30/2020 | Earnings | ACADIA Pharmaceuticals Inc Third Quarter Earnings for 2020 Release |
| 08/05/2020 16:30 EDT | Misc | ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020 |
| 08/05/2020 | Earnings | ACADIA Pharmaceuticals Inc Second Quarter Earnings Result for 2020 |
| 06/23/2020 08:00 PDT | Misc | ACADIA Pharmaceuticals Inc Annual General Meeting for 2019 |
| 05/07/2020 16:30 EDT | Misc | ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020 |
| 05/07/2020 | Earnings | ACADIA Pharmaceuticals Inc First Quarter Earnings Result for 2020 |
| 02/27/2020 | Misc | ACADIA Pharmaceuticals Inc Annual Report for 2019 |
| 02/26/2020 17:00 EST | Misc | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019 |
| 02/26/2020 | Earnings | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.acadia-pharm.com
- Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Oct. 30, 2020
- Last Earnings Release: Aug. 05, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 39.88 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| ASYMX | Alger Weatherbie Specialized Growth Y | 2.58% |
| BTEC | Principal Healthcare Innovators ETF | 1.45% |
| FBIOX | Fidelity® Select Biotechnology | 1.35% |
| CEARX | Columbia Acorn Adv | 1.34% |
| TDB875 | TD Health Sciences Fund - O | 1.20% |
| HQL | Tekla Life Sciences Investors | 1.01% |
| HQH | Tekla Healthcare Investors | 0.84% |
| FGKFX | Fidelity® Growth Company K6 | 0.73% |
| FSSNX | Fidelity® Small Cap Index | 0.33% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ACAD Tweets Stocktwits
Advertisement
